The FDA approved desmopressin acetate (Desmoda) oral solution for the management of central diabetes insipidus in adults and children, developer Eton Pharmaceuticals announced. The vasopressin analog ...

Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions, Inc. Q4 2025 ...

In 2026, Beamr plans to build the foundations of its long-term growth by further developing solutions for video data in AI systems - both for human viewers and for machine vision Herzliya, Israel, Feb ...

Interview: Dr K Rajasekhar, Sr VP (R&D Technology) at Hyderabad-based VoiceGate, shares how the firm plans to fix compliance, ...

Polystar, part of Elisa Industriq, will introduce four new AI-driven capabilities at Mobile World Congress 2026, ...

In its latest Sustainability Report, the state-run hydropower major flags AI/ML-driven performance analytics and early-warning systems as core tools to improve reliability, reduce outage risk and ...

ClearML integrates its AI Infrastructure Platform with the VAST AI Operating System to accelerate enterprise AI ...

FDA authorized desmopressin acetate oral solution (Desmoda) for CDI/AVP-D across all ages, representing the first FDA-approved oral liquid desmopressin formulation in the United States.

Datavault AI (NASDAQ: DVLT) highlighted the strategic importance of its New York and Philadelphia edge network ...

ML is poised to become faster and more accessible by 2026. Simply having the support of GenAI already gives it an advantage over other AI-based solutions.

Drugmaker Lupin on Wednesday said it has initiated launch of Brivaracetam Oral Solution 10 mg/mL in the United States following U.S. Food and Drug Administration (U.S. FDA) approval for its ...